Oncology Institute, Inc. Quarterly Operating Margin in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Oncology Institute, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q3 2024.
  • Oncology Institute, Inc. Operating Margin for the quarter ending September 30, 2024 was -16.8 %, a 40.2% increase year-over-year.
  • Oncology Institute, Inc. annual Operating Margin for 2023 was -23.8 %, a 26.8% increase from 2022.
  • Oncology Institute, Inc. annual Operating Margin for 2022 was -32.5 %, a 43.7% decline from 2021.
  • Oncology Institute, Inc. annual Operating Margin for 2021 was -22.6 %, a 417% decline from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -16.8 +11.3 +40.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -17.6 +14.2 +44.6% Apr 1, 2024 Jun 30, 2024
Q1 2024 -18.1 +17.1 +48.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -23.8 +8.7 +26.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -28 +13.9 +33.1% Jul 1, 2023 Sep 30, 2023
Q2 2023 -31.8 +4.39 +12.1% Apr 1, 2023 Jun 30, 2023
Q1 2023 -35.2 -5.37 -18% Jan 1, 2023 Mar 31, 2023
Q4 2022 -32.5 -9.87 -43.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -41.9 Jul 1, 2022 Sep 30, 2022
Q2 2022 -36.2 Apr 1, 2022 Jun 30, 2022
Q1 2022 -29.9 Jan 1, 2022 Mar 31, 2022
Q4 2021 -22.6 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.